The Latest Life Sciences Tools & Diagnostics Articles from Streetwise Reports

Tech Innovator Achieves Breakthrough Multi-Market Success

Streetwise Reports (01/15/2025)

Clean technology company BioLargo Inc. (BLGO:OTCQX) announces it had a "widely successful" and "transformative" 2024 and is looking forward to more revenue growth in 2025. Read why one expert thinks investors should be doubling down on the stock.

Tags: Life Sciences Tools & DiagnosticsTechnologyMedical Devices

AI Company Unlocks Breakthrough Medical Diagnostics Platform

Streetwise Reports (01/06/2025)

One company being listed on Cboe Canada starting January 8 is using AI and smartphones to help patients get quick and accurate diagnosis of their sore throats, helping to battle microbial resistance that threatens the effectiveness of antibiotics worldwide.

Tags: Life Sciences Tools & DiagnosticsMedical Devices

Is This Centrally Positioned AI Healthcare Co. Set to Transform the Industry?

Contributed Opinion

Clive Maund (12/20/2024)

Technical Analyst Clive Maund explains why he thinks Treatment.com AI Inc. (TRUE:CSE; TREIF:OTCMKTS; 939:FRA) offers potential upside to investors.

Tags: Healthcare ServicesLife Sciences Tools & Diagnostics

AI Accelerates Breakthroughs in Cancer Drug Discovery

Streetwise Reports (12/03/2024)

Rakovina Therapeutics Inc. (RKV:TSX.V) is advancing cancer drug discovery with its Deep Docking AI platform. Read more about their recent developments and future plans.

Tags: Life Sciences Tools & Diagnostics

Transformative Moves in Harm Reduction Expanding Market Reach with New Partnerships and Acquisitions

Streetwise Reports (11/15/2024)

Safe Supply Streaming Co. Ltd (SPLY:CSE; SSPLF:OTCQB; QM4:FSE) recently announced significant developments within its portfolio company, Safety Strips, and a key acquisition. Learn more about how these strategic developments aim to enhance harm reduction efforts and expand market reach.

Tags: Life Sciences Tools & Diagnostics

AI Healthcare Co. With 'Bright' Outlook Closes Placement

Streetwise Reports (10/31/2024)

Healthcare artificial intelligence (AI) company Treatment.com AI Inc. (TRUE:CSE; TREIF:OTCMKTS; 939:FRA) has closed a non-brokered private placement for aggregate gross proceeds of CA$1.95 million. Find out why one analyst says the stock is a Strong Buy and worth going overweight on.

Tags: Life Sciences Tools & DiagnosticsHealthcare ServicesTechnology

Is This AI Healthcare Stock Worth Being Overweight On?

Contributed Opinion

Clive Maund (10/09/2024)

Technical Analyst Clive Maund explains why he thinks Treatment.com AI Inc. (TRUE:CSE; TREIF:OTCMKTS; 939:FRA) is a Strong Buy and worth being overweight on.

Tags: Healthcare ServicesTechnologyLife Sciences Tools & Diagnostics

Healthcare Tech Firm and Leading University to Join Forces

Streetwise Reports (09/07/2024)

The parties intend to develop artificial intelligence-backed solutions to a problem in healthcare, for expanded use throughout and beyond the United Kingdom. Find out why one analyst is bullish on this company and its proprietary platform.

Tags: Life Sciences Tools & DiagnosticsTechnology

AI Healthcare Co. Signs Partnership With Large Regional Health Plan

Research Report

Dr. Jonathan Aschoff (08/09/2024)

Ontrak Inc. (NASDAQ: OTRK) announced it had signed a two-year strategic partnership with a large, northeast regional health plan focused on the plan's New York State members. This development comes as the company continues to rebuild its client base following a significant customer loss in Q1 2024, noted a Roth MKM research note.